Remilk Valuation, Funding & Investors

Remilk is valued at $325M as of January 2022.

Last Remilk valuation

$325M

Series B · Jan 2022

Last Remilk funding round

$120M

Series B · Jan 2022

Cumulative funding Remilk raised

$131M

across 2 funding rounds

Key investors in Remilk

  • Hanaco Venture Capital
  • fresh.fund

Remilk Overview

About Remilk

Remilk is a Tel Aviv-headquartered food technology company that ferments dairy proteins using microbes to produce animal-free milk. Founded in 2019, it replicates cow milk's composition for use in cheese, yogurt, and beverages, targeting sustainable dairy alternatives.


Founded

2019

HQ

IsraelTel Aviv

Website

remilk.com

Status

Privately held

Customer focus

B2B

Revenue model

Product sales

Valuation

$325M (Jan 2022)

Remilk Valuation

Remilk is currently valued at $325M, based on its Series B in January 2022.

The $120M round was led by Hanaco Venture Capital.

Remilk's valuation has grown 11x from $30M at its Series A in December 2020 to $325M in January 2022, across 2 priced rounds.

Remilk valuation by funding round

Remilk valuation by funding round
DateStageValuation
Jan 2022Series B$325M
Dec 2020Series A$30M

Remilk Funding History

Remilk has raised a total of $131M across 2 funding rounds.

Remilk's first fundraising round was a $11M Series A in December 2020. The most recent completed round was a $120M Series B in January 2022.

Remilk funding rounds

Remilk funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Jan 2022Series BHanaco Venture Capital (lead)$120M$325MRemilk is an Israeli food tech startup founded in 2019 that develops animal-free dairy proteins, including milk, using precision fermentation to produce chemically identical proteins to those from cows, targeting products like cheese, yogurt, and ice cream without animal involvement. The company raised $120 million in an oversubscribed Series B funding round on January 4, 2022, led by Hanaco Ventures, with participation from investors including Rage Capital, CPT Capital, Precision Capital, OurCrowd, Tnuva, Fresh Fund, Tal Ventures, and others. This round valued Remilk at $325 million according to multiple reports, marking a 10x increase from its prior $30 million valuation in December 2020, though some sources cited $500 million or a range. The funding enabled Remilk to scale commercial production, with facilities established in Europe and the U.S., and partnerships in discussion with dozens of global food companies and brands for ingredient supply. At the time, Remilk employed about 75 people in Rehovot, Israel, and was navigating regulatory approvals, including with rabbinic authorities. The investment was noted as the largest ever in a cow-free dairy company to date. Remilk operates in the growing dairy alternatives market, projected to expand from $22.25 billion in 2021 to $53.97 billion in 2028, distinct from plant-based milks like those from soy or oats. Competitors include Perfect Day, New Culture Foods, and Change Foods in precision fermentation dairy proteins. Post-round, Remilk planned a major facility in Denmark but later paused it, and continued raising funds, including a $20 million Series C-II in November 2025, bringing total funding to over $131 million.
Dec 2020Series Afresh.fund (lead)$11M$30MRemilk is an Israeli food-technology startup founded in 2019 that produces animal-free dairy products through microbial fermentation technology. The company's proprietary approach creates molecularly identical dairy proteins without using animals, employing precision fermentation to dramatically increase production efficiency compared to traditional dairy manufacturing. In December 2020, Remilk completed a Series A funding round raising $11.3 million at a $30 million post-money valuation. The round was led by early-stage Israeli venture fund fresh.fund and included significant participation from CPT Capital, OurCrowd, ProVeg International, and major food manufacturers Hochland, Tnuva, and Tempo. Notable individual investors included Bradley Bloom, former managing director of Berkshire Partners, along with serial entrepreneurs Amiad Solomon and food-tech investor Beni Nofech. The company aimed to use the capital to rapidly expand production and distribution capabilities to meet growing global demand for animal-free dairy alternatives. Remilk's technology breakthrough increased production of animal-free dairy proteins by an order of magnitude, positioning the startup to compete in the rapidly expanding dairy alternatives market projected to grow from $21.4 billion in 2020 to $36.7 billion by 2025. The Series A represented Remilk's first institutional funding, with existing investors and new backers recognizing the environmental, health, and efficiency benefits of precision fermentation-based dairy protein production. The startup's investors saw significant market potential for its unique technologies across multiple product categories.

Who has invested in Remilk?

2 investors have backed Remilk across its funding rounds, including Hanaco Venture Capital and fresh.fund.

Lead investors include Hanaco Venture Capital and fresh.fund.


Remilk Investors

Investors in Remilk by funding rounds participated
InvestorHQRoundsRoleFirst check

This data is available for Pro users. Sign up to see all 2 Remilk investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Remilk Competitors

Remilk competitors include listed companies like Easy Holdings Co, Cabio Biotech (Wuhan) Co and Itafos, and private ones like The EVERY Company, BlueNalu and Meati.

Public and private companies comparable to Remilk
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Easy Holdings CoSouth KoreaSouth KoreaPublicly listed$2.5B$163M$217M-
Cabio Biotech (Wuhan) CoChinaChinaPublicly listed$84M$33M$211M-
The EVERY CompanyUnited StatesSan Francisco, CAPrivate--$586M-
BlueNaluUnited StatesSan Diego, CAPrivate--$180M-
MeatiUnited StatesBoulder, COPrivate--$650M-
ItafosUnited StatesUnited StatesPublicly listed$558M$189M$335M0.6x

Remilk Public Comps

Remilk is still privately-owned, but its public comps include Canada Packers, Sanford, Itafos, Orsero, Sugat Group, MGP Ingredients, Camil Alimentos, Samyang Holdings, Bonduelle and Tanmiah Food.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Canada Packers$1.3B$149M0.5x0.5x4.3x5.2x
Sanford$335M$84M1.2x1.3x4.9x4.8x
Itafos$558M$189M0.7x0.6x1.9x3.4x
Orsero$2B$95M0.2x0.2x4.7x4.6x
Sugat Group$310M$72M1.2x-5.3x-
MGP Ingredients$536M($69M)1.2x1.3x(9.7x)6.9x
Camil Alimentos$2.2B$188M0.6x0.5x6.5x6.4x
Samyang Holdings$2.4B($83M)0.5x-(16.0x)-

This data is available for Pro users. Sign up to see all Remilk competitors and their valuation data.

Start Free Trial

Common questions about Remilk

When was Remilk founded?Remilk was founded in 2019.
Where is Remilk headquartered?Remilk is headquartered in Tel Aviv, Israel.
Is Remilk publicly listed?No, Remilk is a private, VC-backed company.
What is Remilk's valuation?Remilk was last valued at $325M in its Series B in January 2022.
How much funding has Remilk raised?Remilk has raised $131M across 2 funding rounds.
What was Remilk's last funding round?Remilk's last funding round was a $120M Series B in January 2022, led by Hanaco Venture Capital.
Who are Remilk's investors?Remilk's investors include fresh.fund and Hanaco Venture Capital.
Which companies are comparable to Remilk?Companies comparable to Remilk include Easy Holdings Co, Cabio Biotech (Wuhan) Co, The EVERY Company, BlueNalu, Meati and Itafos.

See companies similar to Remilk

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial